Specifically, they demonstrate slightly delayed resolution of albuminuria in the albumin overload model, only transiently higher albuminuria and a trend toward more glomerular lesions in response to angiotensin II infusion, no enhanced susceptibility to PAN, and no significantly different response to folate-induced AKI and subsequent fibrosis. The gene discussed is AGT; the disease is polyarteritis nodosa.